A clinical trial update was recorded on August 21, 2026, for a study titled "Evaluation of the Safety and Efficacy of Parecoxib in Patients With Subarachnoid Hemorrhage." The trial, registered as NCT06579274, is listed as Phase 2. Its current status is recruiting, meaning the study is actively enrolling participants as of the date noted.
Substance P itself carries an unapproved research status and is not part of this particular trial record, which centers on parecoxib. No results, outcomes, or efficacy data have been posted for this study at this stage. The listing reflects only the trial's design phase and recruitment status, not any findings about safety or benefit.
Readers should note that a recruiting status indicates the trial is ongoing and that conclusions cannot yet be drawn about parecoxib's effects in this patient population. Further updates would be needed to determine whether the study progresses to completion or reports results.
For more background on related research compounds, readers can consult the compound overview page.